U.S. flag

An official website of the United States government

NM_000157.4(GBA1):c.681T>G (p.Asn227Lys) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Aug 8, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000079353.8

Allele description [Variation Report for NM_000157.4(GBA1):c.681T>G (p.Asn227Lys)]

NM_000157.4(GBA1):c.681T>G (p.Asn227Lys)

Genes:
LOC106627981:GBA recombination region [Gene]
GBA1:glucosylceramidase beta 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q22
Genomic location:
Preferred name:
NM_000157.4(GBA1):c.681T>G (p.Asn227Lys)
HGVS:
  • NC_000001.11:g.155238214A>C
  • NG_009783.1:g.11484T>G
  • NG_042867.1:g.4676A>C
  • NM_000157.4:c.681T>GMANE SELECT
  • NM_001005741.2(GBA):c.681T>G
  • NM_001005741.3:c.681T>G
  • NM_001005742.3:c.681T>G
  • NM_001171811.2:c.420T>G
  • NM_001171812.2:c.534T>G
  • NP_000148.2:p.Asn227Lys
  • NP_001005741.1:p.Asn227Lys
  • NP_001005742.1:p.Asn227Lys
  • NP_001165282.1:p.Asn140Lys
  • NP_001165283.1:p.Asn178Lys
  • NC_000001.10:g.155208005A>C
  • NM_001005741.2(GBA):c.681T>G
  • NM_001005741.2:c.681T>G
  • P04062:p.Asn227Lys
Protein change:
N140K
Links:
UniProtKB: P04062#VAR_003275; dbSNP: rs381418
NCBI 1000 Genomes Browser:
rs381418
Molecular consequence:
  • NM_000157.4:c.681T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005741.3:c.681T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005742.3:c.681T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171811.2:c.420T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171812.2:c.534T>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
4

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000111223Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Pathogenic
(May 26, 2017)
germlineclinical testing

Citation Link,

SCV004565297ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process 2024)
Pathogenic
(Aug 8, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown4not providednot providednot providednot providedclinical testing

Details of each submission

From Eurofins Ntd Llc (ga), SCV000111223.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided4not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided4not providednot providednot provided

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV004565297.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The GBA c.681T>G; p.Asn227Lys variant (rs381418), also known as Asn188Lys for legacy nomenclature, is reported in multiple individuals with Gaucher disease or GBA-associated Parkinson's disease (Amico 2016, Germain 1998, Guedes 2017, Kim 2020, Ortiz-Cabrera 2016). This variant is also reported in ClinVar (Variation ID: 93458). It is only found on four alleles in the Genome Aggregation Database, indicating it is not a common polymorphism. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.587). A different variant at this codon, p.Asn227Ser, has also been reported in association with Gaucher disease and is considered to be pathogenic (see ClinVar Variation ID: 4314). Based on available information, the p.Asn227Lys variant is considered to be pathogenic. References: Amico G et al. MLPA-based approach for initial and simultaneous detection of GBA deletions and recombinant alleles in patients affected by Gaucher Disease. Mol Genet Metab. 2016 Dec;119(4):329-337. PMID: 27802905. Germain DP et al. Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease. Am J Hum Genet. 1998 Aug;63(2):415-27. PMID: 9683600. Guedes LC et al. Serum lipid alterations in GBA-associated Parkinson's disease. Parkinsonism Relat Disord. 2017 Nov;44:58-65. PMID: 28890071. Kim YM et al. The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects. Orphanet J Rare Dis. 2020 Nov 11;15(1):318. PMID: 33176831. Ortiz-Cabrera NV et al. Nine-year experience in Gaucher disease diagnosis at the Spanish reference center Fundacion Jimenez Diaz. Mol Genet Metab Rep. 2016 Nov 13;9:79-85. PMID: 27872820.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 30, 2024